The International Agency for Research on Cancer (IARC) is thrilled to announce a groundbreaking partnership with The Lancet for the IARC@60: Cancer Research into Action conference. This collaboration between two of the most esteemed names in research and publishing sets the stage for an extraordinary event that will shape the future of cancer research. But here's where it gets exciting: The Lancet will be involved in three of its high-impact journals, bringing a unique perspective to the conference.
The Lancet will serve as the official Media Partner, leveraging its three influential journals: The Lancet Oncology, The Lancet Public Health, and eClinicalMedicine. A special issue of eClinicalMedicine, published in the lead-up to the conference, will feature a curated selection of abstracts, chosen by Lancet editors. This will provide a sneak peek into the groundbreaking research that will be presented at the event. Additionally, the conference will include a dedicated Lancet session, offering an in-depth exploration of the latest advancements in cancer research.
The IARC@60: Cancer Research into Action conference will take place from May 19-21, 2026, in Lyon, France. The event will delve into three key scientific themes: (1) Discovery and innovation for cancer prevention, (2) Translating research into public health action, and (3) Science–policy interface for global change. This conference aims to bring together experts from around the world to share their insights and drive meaningful progress in cancer research.
The deadline for abstract submission is January 12, 2026. Researchers and professionals are encouraged to submit their work to be considered for presentation at the conference. For more information, visit the dedicated conference website.
Submit your abstract: https://iarc2026conf.iarc.who.int/en/abstracts/14
Visit the conference website: https://iarc2026conf.iarc.who.int/
Visit the IARC@60 celebration website: https://circ60.iarc.who.int/
And this is the part most people miss: The collaboration between IARC and The Lancet is a testament to the power of partnership in advancing cancer research. By bringing together diverse perspectives and expertise, this partnership aims to foster innovation and drive meaningful change. So, what do you think? Do you agree that this collaboration is a significant step forward in cancer research? Share your thoughts in the comments below!
